Evotec and Interprotein Collaborates to Develop Interleukin 6 Inhibitors to Treat Inflammatory Diseases

Find more details from the full report.IL-6 is a crucial cytokine involved in the onset and progression of inflammatory diseases such as e.g. rheumatoid arthritis and cachexia. Based on in silico drug design, Interprotein discovered a number of hit molecules.



.jpg)



Comment Preview